Open AccessNonalcoholic Fatty Liver Disease
Author(s) -
Tyler Thrasher,
Manal F. Abdelmalek
Publication year - 2016
Publication title -
north carolina medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.283
H-Index - 24
eISSN - 2379-4313
pISSN - 0029-2559
DOI - 10.18043/ncm.77.3.216
Subject(s) - nonalcoholic fatty liver disease , medicine , fatty liver , disease
Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is the leading cause of chronic liver disease. Treatments target lifestyle modification and improvement of underlying risk factors. Noninvasive biomarkers for diagnosis and staging of NAFLD and safe, cost-effective treatments for patients with nonalcoholic steatohepatitis (NASH) and/or NASH-related cirrhosis are currently under investigation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom